{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:vasculitis:buerger-disease",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-09T02:00:00.000Z",
    "contributors": [
      "copilot-agent"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/vasculitis/buerger-disease",
    "type": "concept",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "Buerger Disease (Thromboangiitis Obliterans)",
    "summary": "Non-atherosclerotic, segmental inflammatory disease affecting small and medium vessels of the extremities, strongly associated with tobacco use in young patients.",
    "definitions": [
      {
        "term": "Buerger Disease",
        "definition": "Segmental, thrombotic, occlusive, non-atherosclerotic vascular disease affecting small and medium-sized arteries and veins of the extremities, predominantly in young male smokers."
      },
      {
        "term": "Shionoya Criteria",
        "definition": "Clinical diagnostic criteria: (1) smoking history, (2) onset before age 50, (3) infrapopliteal occlusion, (4) upper extremity involvement or phlebitis migrans, (5) absence of atherosclerotic risk factors except smoking."
      }
    ],
    "key_concepts": [
      {
        "concept": "Clinical Presentation",
        "explanation": "Intermittent claudication of foot/arch, rest pain, ischemic ulcers of digits. Superficial thrombophlebitis (migratory). Raynaud's phenomenon in 40%. Upper extremity involvement in 30-50%. Bilateral disease common."
      },
      {
        "concept": "Angiographic Findings",
        "explanation": "Segmental occlusions of small/medium vessels with normal proximal arteries. 'Corkscrew' collaterals (helical vessels around occlusions). Absence of proximal atherosclerotic disease. Skip lesions."
      },
      {
        "concept": "Smoking Cessation - Cornerstone of Treatment",
        "explanation": "Continued smoking leads to 40-50% amputation rate. Complete cessation halts disease progression in 90%+. Even reduction insufficient - must be complete abstinence. Includes all tobacco and cannabis products."
      },
      {
        "concept": "Limited Surgical Options",
        "explanation": "Bypass rarely possible due to distal disease and poor runoff. Sympathectomy may provide symptomatic relief. Iloprost (prostacyclin analog) for rest pain and ulcer healing. Amputation for irreversible ischemia."
      }
    ],
    "evidence": [
      {
        "citation": "Olin et al., TAO Natural History, 2000",
        "finding": "Amputation rate 25% if smoking continues vs 5% if complete cessation is achieved"
      },
      {
        "citation": "TACT Trial (Tateishi-Yuyama et al.), 2002",
        "finding": "Autologous bone marrow cell implantation showed promise for improving ABI and pain in Buerger disease"
      }
    ],
    "clinical_pearls": [
      "Consider Buerger disease in any young smoker with distal extremity ischemia",
      "Upper extremity involvement distinguishes from typical PAD",
      "Superficial thrombophlebitis in a young smoker should raise suspicion",
      "Cotinine levels can confirm smoking status - patients may underreport",
      "Cannabis smoking may also cause or exacerbate Buerger disease"
    ],
    "learning_objectives": [
      "Apply Shionoya criteria for diagnosis of Buerger disease",
      "Recognize angiographic findings characteristic of TAO",
      "Explain why smoking cessation is critical for disease management",
      "Describe limited role of revascularization in Buerger disease",
      "State the role of prostacyclin analogs in treatment"
    ],
    "statement": "Buerger Disease (Thromboangiitis Obliterans) is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Vasculitis Buerger-Disease that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Buerger Disease (Thromboangiitis Obliterans) helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Buerger Disease (Thromboangiitis Obliterans) include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Buerger Disease (Thromboangiitis Obliterans)."
    }
  },
  "relationships": {
    "prerequisites": [
      "vascular:foundations:small-vessel-anatomy"
    ],
    "related_concepts": [
      "vascular:pathology:critical-limb-ischemia",
      "vascular:vasculitis:takayasu-arteritis",
      "vascular:pathology:raynaud-phenomenon"
    ],
    "cross_domain_references": [
      {
        "@id": "pulmonology:smoking-cessation",
        "relationship": "uses",
        "context": "Smoking cessation is the primary treatment"
      }
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Buerger Disease (Thromboangiitis Obliterans). Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}